UBS Group’s Patterson-UTI PTEN Stock Holding History
Bought
Maintained
Sold
Other funds holding PTEN
VPM
VCM
SG
UBS Group's PTEN Position: Q1 2026 in Review
UBS Group reduced its Patterson-UTI (PTEN) stake by 65% in Q1 2026, selling an estimated $46.2M and leaving 2,919,491 shares worth $31.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2112.
UBS Group first reported a position in PTEN in Q4 2014 and has held it in 46 quarters since. The position peaked at $50.8M in Q4 2025. 410 funds tracked by Wall St. Rank hold PTEN as of Q1 2026.
- UBS Group held 2,919,491 shares of Patterson-UTI worth $31.6M as of Q1 2026.
- UBS Group sold 5,401,053 Patterson-UTI shares in Q1 2026, an estimated $46.2M.
- Patterson-UTI made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #2112 holding.
- UBS Group first reported a position in Patterson-UTI in Q4 2014 and has held it in 46 quarters since.
- UBS Group's Patterson-UTI position peaked at $50.8M in Q4 2025.
- 410 funds tracked by Wall St. Rank held Patterson-UTI as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.